SEARCH OF ANTITUMOUR MEDICAL DRUGS BY WAY OF CREATION OF NEW ANTIMETABOLITES OF PYRIMIDINES CHANGE – BIS-DERIVATIVES OF 5(6)- SUBSTITUTED URACILES AND THEIR ADDUCTS WITH BACTERIAL LECTINS
Elena V. Welchinskaya, Valeria V. Vilchinskaya
Страници: 355-361
Публикувана: 1 Jan 2013
Преглеждания: 662
Изтегляния: 70
Резюме: A new convenient method for the preparation of heterocyclic bis-adducts of 5(6)-substituted uraciles with ftorotan (1,1,1-threefluoro-2-bromo-2-chloroethane) is described. The reactions are catalyzed by the 18-crown-6-complex. The structure of synthesized compounds has been confirmed by data of elemental analysis, IR- and ІН-spectra. The new molecular complexes were created on the base of bacterial lectins and some of heterocyclic bis-adducts of 5(6)-substituted uraciles, which synthesized. The critical toxicity and antitumour activity of new bis-adducts, saprophytic stammes Bacillus genus (B. subtilis 668 IMV and B. polymyxa 102 KGU) extracellular lectins and their molecular complexes were studies. It was discovered that these substances apply to little and moderate toxic preparations and has an expression antitumour action on the tumours: Lymphosarcoma Plissa and Sarcoma 45. A strongly antitumour effect of bis-adduct of 5-fluorouracile, bacterial lectins and their molecular complexes (bis-adduct of 5-fluorouracile + B. subtilis 668 IMV or B. polymyxa 102 KGU) has been discovered: growth relaxation of the Lymphosarcoma Plissa tumour mass was 50,0 -75,3%, of the Sarcoma 45: 16,9-81,1%.
Ключови думи: 5-fluorouracile, bacterial lectins, heterocyclic bis-adducts, antitumour effect
Цитирайте тази статия: Elena V. Welchinskaya, Valeria V. Vilchinskaya. SEARCH OF ANTITUMOUR MEDICAL DRUGS BY WAY OF CREATION OF NEW ANTIMETABOLITES OF PYRIMIDINES CHANGE – BIS-DERIVATIVES OF 5(6)- SUBSTITUTED URACILES AND THEIR ADDUCTS WITH BACTERIAL LECTINS. Journal of International Scientific Publications: Materials, Methods & Technologies 7, 355-361 (2013). https://www.scientific-publications.net/en/article/1003116/
Обратно към съдържанието на тома
© 2026 The Author(s). This is an open access article distributed under the terms of the
Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This permission does not cover any third party copyrighted material which may appear in the work requested.
Disclaimer: The Publisher and/or the editor(s) are not responsible for the statements, opinions, and data contained in any published works. These are solely the views of the individual author(s) and contributor(s). The Publisher and/or the editor(s) disclaim any liability for injury to individuals or property arising from the ideas, methods, instructions, or products mentioned in the content.
